Document:

Exhibit 10.1

 

 

 

January 9, 2019

 

Mr. Steven Krause

325 Randolph Street

Burlington, WI 53105

 

via email: SteveKrause815@gmail.com

 

Dear Steve,

 

On behalf of Senestech, I am pleased to
confirm the details of your employment as Executive Vice President Sales & Marketing. We look forward to having you leading
our team and helping us further our growth and profitability. I know Senestech offers the environment and challenges that you seek,
and I am sure you will enjoy the Company.

 

This letter summarizes the basic employment terms and conditions
of our offer. These are:

 

		●	Title:
                                         Executive Vice President of Sales and Marketing

		●	Reports
                                         To: Chief Executive Officer, Mr. Ken Siegel

		●	Start
                                         Date: Monday, February 17, 2020

		●	Compensation:
                                         Base salary of $200,000 per annum plus incentive programs, detailed below. Salary
                                         is paid on a bi-monthly basis, subject to deductions for taxes and other withholdings
                                         as required by law or the policies of the company. Pay dates are the fifteenth and end
                                         of each month. A portion, of all of performance bonuses, may be paid in stock at the
                                         discretion of the Company.

 

		●	Incentive Programs:

 

		○	Bonus Program: You will be eligible to participate
in the Sales Bonus Program. The “target” of your incentive is 25% of your annual salary. Note that the actual annual
award will be determined based on your individual
contribution during each performance year as well as on the results achieved against select metrics of our annual business plan.

 

		○	Stock Option Incentive Program: This award will
be determined based upon your individual contribution and financial results as determined by annual financial targets and key
productivity indicators during the fiscal year. Your award will have a three-year vesting schedule (taxable upon vesting).

 

		○	Other terms of Incentive Programs:

		■	The target amounts, the metrics, pay-out formulas, and
conditions of the Short-Term Incentive and the Long-Term Incentive Program may be periodically revised or altered by the SenesTech
Board of Directors to reflect changing environmental or business conditions. Should changes occur, they will have no retroactive
impact and you will receive appropriate notice.

 

928.779.4143 | 3140 N. Caden Court, Flagstaff, AZ 86004

www.senestech.com

  

     

     

    

 

 

 

		■	Bonuses, if due, are typically paid in within three weeks
following approval of the financial results for the fiscal year and are contingent upon the participant’s continued employment
with the Company at the time they are to be paid.

 

		●	Signing Bonuses:

 

		○	Signing Bonus: In consideration of your acceptance
of a lower base salary, you will be given a one-time bonus of $25,000 cash and 25,000 in company stock options.

 

		■	Stock Options: Subject to approval by the Board of
                                                                                                                            Directors, as part of this employment offer, you will be granted options to purchase 25,000 shares of the
                                                                                                                            Company’s common stock at the fair market value as determined by the Board of Directors as of the date of grant (the
                                                                                                                            “Option”). The Option will expire five years from the date of grant and will vest 1/36th per month over the
                                                                                                                            first three years. All terms, conditions, and limitations of the Option will be set forth in your grant notice and agreement
                                                                                                                            and the Option will be governed by the Company’s 2018 Equity Incentive Plan (the “Plan”). If you have
                                                                                                                            additional questions, or would like a copy of the Plan, please let us know.

 

		○	Forgone Bonus: In consideration of your foregone
compensation at your previous employer, the Company will pay you a one-time Sign-On Bonus of $60,000, minus all appropriate deductions
for local, state, federal and payroll tax withholdings. This Bonus will be paid in the first pay period in May.

 

		●	Vacation
                                         and Sick Time: You will be entitled to 20 days (four weeks) of vacation per year and
                                         five days (one week) of sick per year. To the extent possible, time off should be scheduled
                                         in consultation with your supervisor to minimize the disruption to the Company’s business. Senior leadership are encouraged to take some personal time each quarter
                                         to foster a positive work-life balance. Vacation and sick leave are provided on an accrual
                                         basis and employees begin to accrue from the first day of employment. Additionally, you
                                         will be awarded two personal/floating holidays which can be used in addition you your
                                         annual vacation and sick. Unused vacation can be carried over year-to-year, up to twice
                                         your annual award. Unused sick time and floating holidays do not carry over but are reset
                                         annually each January.

 

		●	Holidays: The following twelve paid holidays are
recognized by the Company; each calendar year may vary slightly depending on the day of the week on which the holiday falls:

 

		○	New Year’s Day

		○	Martin Luther King, Jr. Day

		○	Staff Appreciation Day (3rd Friday in March)

		○	Memorial Day

		○	Independence Day

		○	Labor Day

		○	Veteran’s Day

		○	Thanksgiving Day and Friday following

		○	Christmas Eve and Christmas Day

		○	New Year’s Eve (most years)

 

		●	Benefits:
This position is eligible for all company benefits. We provide health care coverage through ADP Total Source & United Healthcare,
with an employer contribution. We offer medical, dental, vision, and basic life insurance plans. You will become eligible for the
Company’s employee benefits on the first day of the month following your start date. More detailed benefit information is provided
through ADP, following your on-boarding. Copies of our plan details can be provided upon request.

 

928.779.4143 | 3140 N. Caden Court, Flagstaff, AZ 86004

www.senestech.com

  

     

     

    

 

 

 

		●	Upon completion of your first 90 days with SenesTech
you will be eligible for the 401(K) program. Please note we do not currently offer employer-match but hope to in the future.

 

		●	Location &
Support: While this position is housed in our corporate offices in Phoenix, Arizona with frequent domestic travel
required, there is no expectation for your relocation at this time. SenesTech, will provide you necessary equipment and materials
to telecommute from your home.

 

		○	SenesTech will coordinate your professional travel to
ensure compliance with our travel polices and use of preferred vendors. Additionally, reasonable expenses incurred during the
course of business will be reimbursed.

		○	SenesTech will provide you administrative support and
access to business tools to effectively manage your team and meet your performance goals.

 

As with all our employees, your employment
at Senestech is  “at -will”. This means that your employment continues so long as both SenesTech and you agree that
it should. Both SenesTech and you have the right to terminate the employment relationship at any time and for any, or no, reason.

 

This letter will supersede any prior
oral or written understanding concerning compensation or other terms of your employment, and any changes with respect to your
compensation arrangements must be in writing and signed on behalf of SenesTech.

 

Congratulations on your role as Executive
Vice President Sales & Marketing for SenesTech. Those of us who met with you during the interview process were very impressed
with your qualifications, accomplishments, and capabilities. We believe that you are a very good fit with our team overall and
are optimistic that you will accept our offer. We look forward to you joining SenesTech.

 

If you find these terms acceptable, please
sign a copy of this letter in the space provided below, scan it, and e-mail it back by 13 January 2020. If you have any questions,
do not hesitate to contact me at (928) 310-8210

 

Sincerely,

 

	/s/ Ken Siegel	 
	Ken Siegel	 
	Chief Executive Officer	 

 

This letter has been read and fully understood. I accept all
the terms of employment as specified.

  

	/s/ Steven Krause	 	12 January 2020	 
	Steven Krause	 	Date	 

 

CC: HR File

 

928.779.4143 | 3140 N. Caden Court, Flagstaff, AZ 86004

www.senestech.comExhibit 10.1

 

EXCHANGE AGREEMENT

 

EXCHANGE AGREEMENT
(the “Agreement”) is made as of the ___ day of April 2020, by and between Uppercut Brands, Inc.,
a Delaware corporation (the “Company”), and the investor signatory hereto (the “Investor”).

 

WHEREAS, the
Company has previously issued to the Investor (i) a certain Convertible Promissory Note (the “Note”), and (ii)
warrants to purchase shares of common stock of the Company, par value $0.0001 per share (the “Warrants” and
together with the Note, the “Existing Securities”), which were issued pursuant to a securities purchase agreement
entered into on October __, 2019 (the “Purchase Agreement”);

 

WHEREAS, as
of the date hereof, the Investor holds (i) a Note in the aggregate principal amount, and (ii) warrants to purchase shares of common
stock, set forth an on the Investor’s signature page attached hereto;

 

WHEREAS, subject
to the terms and conditions set forth in this Agreement and in reliance on Section 3(a)(9) of the Securities Act of 1933, as amended
(the “Securities Act”) and/or Section 4(a)(2) of the Securities Act, the Company desires to exchange
with the Investor, and the Investor desires to exchange with the Company, the Existing Securities for shares of newly issued common
stock of the Company, par value $0.0001 per share (the “Common Stock”), on the basis one share of Common Stock for
each share $0.08 of principal due on the Note; and

 

NOW, THEREFORE,
for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, and in consideration of
the premises and the mutual agreements, representations and warranties, provisions and covenants contained herein, the parties
hereto, intending to be legally bound hereby, agree as follows:

 

1. Exchange;
Waiver. On Closing Date (as defined below), subject to the terms and conditions of this Agreement, the Investor shall, and
the Company shall, pursuant to Section 3(a) (9) of the Securities Act and/or 4(a)(2) of the Securities Act, exchange the Existing
Securities held by the Investor for shares of Common Stock on the basis one share of Common Stock for each share $0.08 of principal
due on the Note. Subject to the conditions set forth herein, the exchange of the Existing Securities for the shares of Common Stock
shall take place at the offices of the Company, within 2 Trading Days of the date hereof, or at such other time and place as the
Company and the Investor mutually agree (the “Closing” and such date, the “Closing Date”).
At the Closing, the following transactions shall occur (such transaction an “Exchange”):

 

1.1 On
the Closing Date, in exchange for the Note, the Company shall deliver shares of Common Stock to the Investor or its designee in
accordance with the Investor’s delivery instructions set forth on the Investor signature page hereto. Upon receipt of the
shares of Common Stock in accordance with this Section 1.1, all of the Investor’s rights under the Existing Securities shall
be extinguished. The Investor shall tender to the Company the Existing Securities within three Trading Days (as defined below)
of the Closing Date.

  

    -1-

     

    

 

1.2 On
the Closing Date, the Investor shall be deemed for all corporate purposes to have become the holder of record of the shares of
Common Stock, and the Existing Securities shall be deemed for all corporate purposes to have been cancelled, irrespective of the
date such shares of Common Stock are delivered to the Investor in accordance herewith. Until the Existing Securities has been delivered
to the Company, the Investor shall bear the risk that they are acquired by a bona fide purchaser with no notice of the Investor’s
and the Company’s claims.

 

As used herein, “Common
Stock” means the common stock of the Company, par value $0.001 per share, and any other class of securities into
which such securities may hereafter be reclassified or changed.

 

As used herein, “Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

As used herein, “Trading
Day” means any day on which the Common Stock is traded on the principal securities exchange or securities market
on which the Common Stock is then traded.

 

1.3 The
Company and the Investor shall execute and/or deliver such other documents and agreements as are customary and reasonably necessary
to effectuate the Exchanges, including, at the request of the Company or its transfer agent, executed stock powers in customary
form.

 

1.4 Subject
to the terms hereof, Investor hereby irrevocably waives the any and all interest that was due and owing on the Note on or prior
to the Execution Date as well as any penalties, interest or other amounts that may have accrued under the Existing Securities.
This waiver does not include any default or breach occurring after the Execution Date should the Closing not occur.

 

1.5 Investor
hereby waives any compliance by the Company with Sections 4.12, 4.13 and 4.17 of the Purchase Agreement in connection with the
transactions contemplated by this Agreement.

 

2. Closing
Conditions.

 

2.1 Conditions
to Investor’s Obligations. The obligation of the Investor to consummate the Exchange is subject to the fulfillment, to
the Investor’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a) Representations
and Warranties. The representations and warranties of the Company contained in this Agreement shall be true and correct in
all material respects on the date hereof and on and as of the Closing Date as if made on and as of such date.

 

(b) No
Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit or obtain substantial damages
in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

  

    -2-

     

    

 

(c) Proceedings
and Documents. All proceedings in connection with the transactions contemplated hereby and all documents and instruments incident
to such transactions shall be satisfactory in substance and form to the Investor, and the Investor shall have received all such
counterpart originals or certified or other copies of such documents as they may reasonably request.

 

(d) Consents.
The Company shall have obtained all required consents.

 

2.2 Conditions
to the Company’s Obligations. The obligation of the Company to consummate the Exchange is subject to the fulfillment,
to the Company’s reasonable satisfaction, prior to or at the Closing, of each of the following conditions:

 

(a) Representations
and Warranties. The representations and warranties of the Investor contained in this Agreement shall be true and correct in
all material respects on the date hereof and on and as of the Closing Date as if made on and as of such date.

 

(b) No
Actions. No action, proceeding, investigation, regulation or legislation shall have been instituted, threatened or proposed
before any court, governmental agency or authority or legislative body to enjoin, restrain, prohibit, or obtain substantial damages
in respect of, this Agreement or the consummation of the transactions contemplated by this Agreement.

 

(c) Proceedings
and Documents. All proceedings in connection with the transactions contemplated hereby and all documents and instruments incident
to such transactions shall be satisfactory in substance and form to the Company and the Company shall have received all such counterpart
originals or certified or other copies of such documents as the Company may reasonably request.

 

3. Representations
and Warranties of the Company. The Company hereby represents and warrants to Investor that:

 

3.1 Organization,
Good Standing and Qualification. The Company is a corporation duly organized, validly existing and in good standing under the
laws of the State of Nevada. The Company is duly qualified to transact business and is in good standing in each jurisdiction in
which the failure to so qualify would have a material adverse effect on its business or properties.

 

3.2 Authorization.
All corporate action on the part of the Company, its officers, directors and stockholders necessary for the authorization, execution
and delivery of this Agreement and the performance of all obligations of the Company hereunder, and the authorization (or reservation
for issuance of), the Exchanges, and the issuance of the shares of Common Stock, have been taken on or prior to the date hereof.

  

    -3-

     

    

 

3.3 Valid
Issuance of the Shares. The Shares, when issued and delivered in accordance with the terms of this Agreement, for the consideration
expressed herein, will be duly and validly issued, fully paid and non-assessable.

 

3.4 Compliance
With Laws. The Company has not violated any law or any governmental regulation or requirement which violation has had or would
reasonably be expected to have a material adverse effect on its business and the Company has not received written notice of any
such violation.

 

3.5 Consents;
Waivers. No consent, waiver, approval or authority of any nature, or other formal action, by any Person, not already obtained,
is required in connection with the execution and delivery of this Agreement by the Company or the consummation by the Company of
the transactions provided for herein and therein.

 

3.6 Acknowledgment
Regarding Investor’s Purchase of Securities. The Company acknowledges and agrees that the Investor is acting solely in
the capacity of arm’s length Investor with respect to this Agreement and the other documents entered into in connection herewith
(collectively, the “Transaction Documents”) and the transactions contemplated hereby and thereby and
that the Investor is not (i) an officer or director of the Company, (ii) an “affiliate” of the Company (as defined
in Rule 144 promulgated under the Securities Act), or (iii) to the knowledge of the Company, a “beneficial owner” of
more than 10% of the shares of Common Stock (as defined for purposes of Rule 13d-3 of the Securities Exchange Act of 1934, as amended).
The Company further acknowledges that the Investor is not acting as a financial advisor or fiduciary of the Company (or in any
similar capacity) with respect to the Transaction Documents and the transactions contemplated hereby and thereby, and any advice
given by the Investor or any of its representatives or agents in connection with the Transaction Documents and the transactions
contemplated hereby and thereby is merely incidental to the Investor’s acceptance of the shares of Common Stock. The Company
further represents to the Investor that the Company’s decision to enter into the Transaction Documents has been based solely
on the independent evaluation by the Company and its representatives.

 

3.7 Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government
agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company,
the Securities or any of the Company’s officers or directors in their capacities as such.

 

3.8 RESERVED.

  

    -4-

     

    

 

3.9 Validity;
Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Company is a party have been duly and
validly authorized, executed and delivered on behalf of the Company and shall constitute the legal, valid and binding obligations
of the Company enforceable against the Company in accordance with their respective terms, except as such enforceability may be
limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. The execution,
delivery and performance by the Company of this Agreement and each Transaction Document to which the Company is a party and the
consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational
documents of the Company or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company is a party or by which it is bound, or (iii) result in a violation of any law, rule,
regulation, order, judgment or decree (including federal and state securities or “blue sky” laws) applicable to the
Company, except in the case of clause (ii) above, for such conflicts, defaults or rights which would not, individually or in the
aggregate, reasonably be expected to have a material adverse effect on the ability of the Company to perform its obligations hereunder.

 

3.10 Disclosure.
The Company confirms that neither it nor any other Person acting on its behalf has provided the Investor or its agents or counsel
with any information that constitutes or could reasonably be expected to constitute material, nonpublic information. The Company
understands and confirms that the Investor will rely on the foregoing representations in effecting transactions in the shares of
Common Stock.

 

3.11 Bring-Down
of Representations and Warranties. All legal and factual representations and warranties made by the Company to the Investor
in any prior agreements pursuant to which the Existing Securities were originally issued are accurate and complete in all material
respects as of the date hereof, unless as of a specific date therein in which case they shall be accurate as of such date (or,
to the extent representations or warranties are qualified by materiality or Material Adverse Effect (as defined in such agreements),
in all respects).

 

3.12 No
Commission Paid. Neither the Company nor any of its affiliates nor any Person acting on behalf of or for the benefit of any
of the foregoing, has paid or given, or agreed to pay or give, directly or indirectly, any commission or other remuneration (within
the meaning of Section 3(a) (9) of the Securities Act and the rules and regulations of the Securities and Exchange Commission promulgated
thereunder) for soliciting the Exchange.

 

3.13 Tacking
of Common Stock. The Company acknowledges and agrees that in accordance with Rule 144(d)(3)(ii)
of the Securities Act, the shares of Common Stock shall take on the characteristics of the Note, and the holding period of the
Common Stock being issued may be tacked on to the holding period of the Note.  The Company agrees not to take any position
contrary to this Section 3.13.

 

4. Representations
and Warranties of the Investor. The Investor hereby represents, warrants and covenants that:

 

4.1 Authorization.
The Investor has full power and authority to enter into this Agreement, to perform its obligations hereunder and to consummate
the transactions contemplated hereby and has taken all action necessary to authorize the execution and delivery of this Agreement,
the performance of its obligations hereunder and the consummation of the transactions contemplated hereby.

  

    -5-

     

    

 

4.2 Investment
Experience. The Investor can bear the economic risk of its investment in the Securities, and has such knowledge and experience
in financial and business matters that it is capable of evaluating the merits and risks of an investment in the shares of Common
Stock.

 

4.3 Information.
The Investor and its advisors, if any, have been furnished with all materials relating to the business, finances and operations
of the Company and materials relating to the offer and issuance of the shares of Common Stock which have been requested by the
Investor. The Investor has had the opportunity to review the Company's filings with the Securities and Exchange Commission. The
Investor and its advisors, if any, have been afforded the opportunity to ask questions of the Company. Neither such inquiries nor
any other due diligence investigations conducted by the Investor or its advisors, if any, or its representatives shall modify,
amend or affect the Investor’s right to rely on the Company’s representations and warranties contained herein. The
Investor understands that its investment in the shares of Common Stock involves a high degree of risk. The Investor has sought
such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its
acquisition of the shares of Common Stock. The Investor is relying solely on its own accounting, legal and tax advisors, and not
on any statements of the Company or any of its agents or representatives, for such accounting, legal and tax advice with respect
to its acquisition of the shares of Common Stock and the transactions contemplated by this Agreement.

 

4.4 No
Governmental Review. The Investor understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the shares of Common Stock or the fairness or suitability of
the investment in the Shares nor have such authorities passed upon or endorsed the merits of the offering of the shares of Common
Stock.

 

4.5 Validity;
Enforcement; No Conflicts. This Agreement and each Transaction Document to which the Investor is a party have been duly and
validly authorized, executed and delivered on behalf of the Investor and shall constitute the legal, valid and binding obligations
of the Investor enforceable against the Investor in accordance with their respective terms, except as such enforceability may be
limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other
similar laws relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies. The execution,
delivery and performance by the Investor of this Agreement and each Transaction Document to which the Investor is a party and the
consummation by the Investor of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational
documents of the Investor or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Investor is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment
or decree (including federal and state securities or “blue sky” laws) applicable to the Investor, except in the case
of clause (ii) above, for such conflicts, defaults or rights which would not, individually or in the aggregate, reasonably be expected
to have a material adverse effect on the ability of the Investor to perform its obligations hereunder.

  

    -6-

     

    

 

4.6 Bring-Down
of Representations and Warranties. All legal and factual representations and warranties made by the Investor to the Company
in any prior agreements pursuant to which the Existing Securities were originally issued are accurate and complete in all material
respects as of the date hereof, unless as of a specific date therein in which case they shall be accurate as of such date (or,
to the extent representations or warranties are qualified by materiality or Material Adverse Effect (as defined in such agreements),
in all respects).

 

5. Additional
Covenants.

 

5.1 Disclosure.
The Company shall, on or before 9:30 a.m., New York City time, on the fourth business day after the date of this Agreement, issue
a Current Report on Form 8-K (the “8-K Filing”) disclosing all material terms of the transactions contemplated
hereby. From and after the issuance of the 8-K Filing, the Investor shall not be in possession of any material, nonpublic information
received from the Company or any of its respective officers, directors, employees or agents that is not disclosed in the 8-K Filing.
The Company shall not, and shall cause its officers, directors, employees and agents, not to, provide the Investor with any material,
nonpublic information regarding the Company from and after the filing of the 8-K Filing without the express written consent of
the Investor. The Company shall not disclose the name of the Investor in any filing, announcement, release or otherwise, unless
such disclosure is required by law or regulation. In addition, effective upon the filing of the 8-K Filing, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the one hand, and the
Investor or any of its affiliates, on the other hand, shall terminate.

 

5.2 Fees
and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and
all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this
Agreement.

 

6. Miscellaneous.

 

6.1 Successors
and Assigns. Except as otherwise provided herein, the terms and conditions of this Agreement shall inure to the benefit of
and be binding upon the parties hereto and the respective successors and assigns of the parties. Nothing in this Agreement, express
or implied, is intended to confer upon any party, other than the parties hereto or their respective successors and assigns, any
rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

  

    -7-

     

    

 

6.2 Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict
of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the
laws of any jurisdictions other than the State of New York. Each party hereby irrevocably submits to the exclusive jurisdiction
of the state or federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees
not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court,
that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is
improper. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit,
action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this Agreement and agrees
that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH
OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

6.3 Titles
and Subtitles. The titles and subtitles used in this Agreement are used for convenience only and are not to be considered in
construing or interpreting this Agreement.

 

6.4 Notices.
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered pursuant to the terms of the March Purchase Agreement and the August Purchase
Agreement.

 

6.5 Amendments
and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived (either
generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company
and the Investor. Any amendment or waiver effected in accordance with this paragraph shall be binding upon Investor and the Company,
provided that no such amendment shall be binding on a holder that does not consent thereto to the extent such amendment treats
such party differently than any party that does consent thereto.

 

6.6 Severability.
If one or more provisions of this Agreement are held to be unenforceable under applicable law, such provision shall be excluded
from this Agreement and the balance of the Agreement shall be interpreted as if such provision were so excluded and shall be enforceable
in accordance with its terms.

 

6.7 Entire
Agreement. This Agreement represents the entire agreement and understanding between the parties concerning the Exchange and
the other matters described herein and therein and supersede and replaces any and all prior agreements and understandings solely
with respect to the subject matter hereof and thereof.

 

6.8 Counterparts.
This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.

  

    -8-

     

    

 

6.9 Interpretation.
Unless the context of this Agreement clearly requires otherwise, (a) references to the plural include the singular, the singular
the plural, the part the whole, (b) references to any gender include all genders, (c) “including” has the inclusive
meaning frequently identified with the phrase “but not limited to” and (d) references to “hereunder” or
“herein” relate to this Agreement.

   

6.10 No
Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

6.11 Survival.
The representations, warranties and covenants of the Company and the Investor contained herein shall survive the Closing and delivery
of the shares of Common Stock.

 

6.12 Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

6.13 No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

[SIGNATURES
ON THE FOLLOWING PAGES]

  

    -9-

     

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

	 	THE COMPANY
	 	 
	 	UPPERCUT BRANDS, INC.
	 	 
	 	By:	        
	 	Name:	 
	 	Title:	 

  

    -10-

     

    

 

IN WITNESS WHEREOF,
the parties have caused this Agreement to be duly executed and delivered as of the date provided above.

 

INVESTOR

 

Name of Investor: ________________________________________________________

 

Signature of Authorized Signatory of
Investor: __________________________________

 

Name of Authorized Signatory: ____________________________________________________

 

Title of Authorized Signatory: _____________________________________________________

 

Email Address of Authorized Signatory:
_____________________________________________

 

Address for Delivery of Shares to Investor:___________________________________________

 

Principal Amount of Note: $_____________________

 

Number of Warrants: _____________________

 

 

-11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00307-of-00352.parquet"}]]